CrossrefInfokarte
Patterns of multimodal MRD response and toxicity with blinatumomab and tyrosine kinase inhibitors in Philadelphia‐positive acute B‐lymphoblastic leukaemia
British Journal of Haematology · 2026-11-06
DOI: 10.1111/bjh.70938 ↗Abstract
Kein Abstract verfügbar.
EUVIMED